IGFBP5 and pachyonychia congenita: In the area of urological cancer, it was reported that IGFBP-5 enhances the anti-apoptotic and mitogenic effects of IGF-I, and accelerates the androgen-independence of PC by the PI3K-AKT protein kinase B signalling pathway36.